Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 22/08/20001 min de leitura
Ophthalmic and Topical Dosage Form New Animal Drugs; 2-Mercaptobenzothiazole Solution
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Combe, Inc. The supplemental NADA provides for the topical use of 2-mercaptobenzothiazole solution as an aid in the treatment of certain common skin inflammations in dogs.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →